Accelerate Development by leveraging China Resources

1
Accelerate Development by leveraging China
Resources

• Guo-Liang Yu, Ph.D
• Chairman, President and CEO
• Guoliang.yu_at_epitomics.com
• 510-517-4925
• www.epitomics.com

2
Company Overview

• Powerful antibody technology (RAbMAb) with strong
  IP
• Very high affinity and specificity
• Novel epitope recognition
• Diverse response with less immunodominance
  excellent response to small epitopes
• 120 employees in US and China
• 36 in Burlingame CA, USA
• 85 in Hangzhou, Zhejiang, China
• Marketed research products and capabilities,
  brand name recognition and strong customer base

3
Epitomics Business
Service
Reagent
RabMAb Technology
Personalized Diagnostics
4
One Stone, Three Birds Approach
5
RabMAbs for drug discovery and validation

• Fully validated antibodies
• Multiple applications
• Biological assays

6
Develop Novel Biomarkers for breast carcinoma
Disease-free survival
8 years
Disease-free survival
8 years
7
Epitomics China Advantages

• Competitive advantages in cost and speed
• Stable and predictable product development
  outcome
• Expanded research and clinical capability

8
Productivity Measurement
of productivity and Success rate compare to the
US operation
2004
2005